Phase III studies enrolled more than 1,400 patients and demonstrated that exenatide effectively lowered blood glucose while producing an unexpected but welcome side effect: weight loss
The company claims its semaglutide drops, which are applied under the tongue, contain the same active ingredient found in Ozempic and Wegovy and provide the powerful benefits of GLP-1 without injections. EllieMD further touts, under a benefits tab on the drops product page, that the drops offer prescription appetite suppression and are scientifically backed to help users lose weight, adding that the drops can help to lower blood sugar levels and potentially reduce the risk factors associated with conditions like type 2 diabetes, high blood pressure and cardiovascular disease, which are often linked to diabetes. Meanwhile, a recent EllieMD Instagram post boasts about the cardiovascular benefits of its GLP-1 medication, including decreased risk of cardiovascular disease, heart attack and stroke
Your body releases GLP-1 when you eat, stimulating insulin secretion that stabilizes blood sugar levels and increases sensations of fullness
Learn from other states efforts to expand OUD services, strengthen #ContinuityOfCare, and support successful recovery by accessing the Serving People with Opioid Use Disorder During Reentry toolkit: #PublicHealth #Medicaid #SubstanceUseDisorder #CriminalJusticeReform #OpioidResponse #Reentry To view or add a comment, sign in #DidYouKnow that ADVI Health's strategic analytics, value and economics (SAVEs) claims data represents 225,988 #Medicare FFS beneficiaries with a #breastcancer diagnosis as of 2023
When lifestyle interventions such as diet and exercise prove insufficient, pharmacological treatments play a crucial role
